In 1998 Congress created the Morris K. Udall Centers of Excellence for Parkinson's Disease Research (Udall Centers). The primary goal of the Udall Centers is to develop new clinical treatments for Parkinson's disease. However, it is well recognized that because there is so much that we do not yet understand about the causes of Parkinson's disease, basic science is currently a key component of the overall effort to develop clinical treatments.
What is Parkinson’s disease?
Parkinson’s disease is a neurodegenerative disorder that affects more than 1 percent of people over age 60. There are currently no proven treatments to slow or halt disease progression.
Learn more about Parkinson’s disease at the Johns Hopkins Parkinson’s Disease and Movement Disorders Center.
The Udall Center at Johns Hopkins
One of the goals of the Udall Centers is to provide an infrastructure that efficiently facilitates a rapid translation from research to clinical when promising breakthroughs occur.
Over the last year The Johns Hopkins University School of Medicine Udall Center has made significant steps toward understanding the underlying mechanisms of Parkinson’s disease and have yielded promising targets for developing treatments against the disease.